Healthtronics Inc

Healthtronics — Investor Presentation (August 2006)

11 slides from Healthtronics's investor presentation, Aug 16, 2006

  1. Slide 1: Presentation of HealthTronics

    Exhibit 99.1 Presentation of HealthTronics August 2006 Sam B. Humphries CFO

  2. Slide 2: Forward-looking statements

    Statements in this presentation that are not strictly historical, including statements regarding plans, objectives and future financial performance, are “forward-looking” statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although

  3. Slide 3: Business Segments/Sub-Segments

    Business Segments/Sub-Segments Urology Services Lithotripsy Prostate Therapies Medical Products Sales Service Anatomical Pathology HIFU Clinical trials

  4. Slide 4: Urology Services

    Urology Services Leading Competitive Position Partner with approximately 1/3 of Nation’s Urologists Veteran Management Team Bringing Cutting-edge Therapies to Market Successful Partnership Model Proven Execution

  5. Slide 5: Urology Services: Core Objectives

    Urology Services Core Objectives ~ Leverage Urology Channel Trusted Advisor to our Partners Value-added Products and Services Facilitate Marketplace Consolidation Growing Revenue & Taking Share Expanding Platform Expand Margins Pricing Stability Wholesale Pricing Power Operating Efficiencies

  6. Slide 6: Prostate Therapy - BPH

    Prostate Therapy - BPH Benign Prostatic Hyperplasia Non-cancerous Enlargement of the Prostate Market Scope Affects 50% of Men Over Age 60 13 Million American Men in 2004 Growth Rate From 40,000 to 360,000 Minimally Invasive Treatments $650 Million - $700 Million Market Multiple Treatment Methodologi

  7. Slide 7: Prostate Therapy - Prostate Cancer

    Prostate Therapy - Prostate Cancer Market Scope Second Most Common Cancer in American Males 230,000 New Cases per Year in the U.S. Baby Boomer Impact (approximately 40 million males) $5B market Dramatic Increase in Public Awareness Demanding Focal Therapy vs. Total Ablation Participating in the Diag

  8. Slide 8: Medical Products: Devices

    Medical Products Devices Lithotripters Market Scope: Total US Installed Base of 650 Units Average Selling Price of $390,000 35% of US Market is Spark Gap Technology US HTRN Manufactured Installed Base of 220 Units Opportunities: Dual Branding Strategy to Expand Spark Gap Market New Model with Multi-

  9. Slide 9: Medical Products: Service Engineering

    Medical Products Service Engineering Installed Base/Network: Currently Service Approximately a Third of US Lithotripter Installed Base 36 Field Engineers Trained in Lithotripsy and X-Ray Additional Consumable Revenue

  10. Slide 10: Medical Products: Uropathology Market

    Medical Products Uropathology Market Market is Approximately $500 Million 8,400 Private Practice Urologists Approximately 10 Prostate Biopsies / Month Each Patient = Approximately $600 Revenue 60% of Patients are Medicare Medicare Reimbursement is Strong

  11. Slide 11: Strategic Initiatives

    Strategic Initiatives With the completion of the sale of our specialty vehicle division, we are performing a comprehensive strategic review and reorganization of many aspects of our business. Any prior earnings guidance for 2006 should not be used or relied upon. We expect this reorganization will r

HealthTronics — Investor Presentation (August 2006) on 6ix